Recent studies even reported > 90% specificity for their improved diagnostic accuracy of multiplex biomarker panels using BDNF with inflammatory markers, e.g., IL-6, TNF-α, to also differentiate treatment-resistant depression from other depressive subtypes [174]. This evidence concerns the gene BDNF and depressive symptom measurement.